Vascular dysfunction as a target for adjuvant therapy in cerebral malaria
AUTOR(ES)
Carvalho, Leonardo José de Moura, Moreira, Aline da Silva, Daniel-Ribeiro, Cláudio Tadeu, Martins, Yuri Chaves
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
2014-08
RESUMO
Cerebral malaria (CM) is a life-threatening complication of Plasmodium falciparum malaria that continues to be a major global health problem. Brain vascular dysfunction is a main factor underlying the pathogenesis of CM and can be a target for the development of adjuvant therapies for the disease. Vascular occlusion by parasitised red blood cells and vasoconstriction/vascular dysfunction results in impaired cerebral blood flow, ischaemia, hypoxia, acidosis and death. In this review, we discuss the mechanisms of vascular dysfunction in CM and the roles of low nitric oxide bioavailability, high levels of endothelin-1 and dysfunction of the angiopoietin-Tie2 axis. We also discuss the usefulness and relevance of the murine experimental model of CM by Plasmodium berghei ANKA to identify mechanisms of disease and to screen potential therapeutic interventions.
Documentos Relacionados
- Modulation of cerebral malaria by curcumin as an adjunctive therapy
- Apoptosis as a target for gene therapy in rheumatoid arthritis
- Sphingolipid synthesis as a target for chemotherapy against malaria parasites.
- Artemether is as good as quinine for cerebral malaria in children
- Cryosurgery as adjuvant therapy in cutaneous sporotrichosis